Atlas FDA

GEM21S Growth Factor Enhanced Matrix

FDA premarket approval P040013/S022 · decided 2019-08-19

Approval details

PMA number
P040013
Supplement
S022
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
GEM21S Growth Factor Enhanced Matrix
Generic name
Bone grafting material, dental, with biologic component
Applicant
Lynch Biologics, LLC
Date received
2019-03-21
Decision date
2019-08-19
Days to decision
151 days
Decision code
APPR
Product code
NPZ
Advisory committee
Dental
Expedited review
No
Location
Franklin, TN
Statement
Approval to change the supplier who fills the B-TCP cup component of the GEM21S device from A+ Secure Packaging to Alliance Contract Pharma.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.